Koldakt Flyu Plus - instructions for use, dose, side effects, contraindications

Auxiliary Ingredients: methylparahydroxybenzoate, propyl parahydroxybenzoate, sodium saccharinate, disodium edetate, sodium chloride, sucrose, microcrystalline cellulose and carmellose sodium, xanthan gum, glycerol, silicon dioxide colloid, polysorbate, citric acid, sodium citrate, dye yellow, orange flavor 051941CS2, aromatic raspberry 502700С, pineapple flavor 503092С, purified water.

Description:Suspension orange with a characteristic odor.

Pharmacotherapeutic group:ARI and "colds" of symptoms remedy (analgesic non-narcotic means + alpha-adrenomimetic + H1-histamine receptor blocker)

ATX: & nbsp

N.02.B.E Anilides

N.02.B.E.51 Paracetamol in combination with other drugs, excluding psycholeptics

Pharmacodynamics:

Combined drug. Chlorphenamine has an antiallergic effect, eliminates tearing, itching in the eyes and nose. Paracetamol has antipyretic and analgesic effect: reduces pain syndrome, which is observed in catarrhal conditions - sore throat, headache, muscle and joint pain, reduces heat. Phenylephrine has vasoconstrictive effect - reduces edema and hyperemia of the mucous membranes of the upper respiratory tract and accessory sinuses of the nose.

Indications:Symptomatic treatment of "cold" diseases, flu, ARVI (febrile syndrome, pain syndrome, rhinorrhea).

Contraindications:

Hypersensitivity to any of the constituent components, pronounced arteriosclerosis of the coronary arteries, arterial hypertension, diabetes mellitus, thyrotoxicosis, angle-closure glaucoma, severe liver, kidney, heart, bladder, stomach ulcer and duodenal ulcer, pancreatic disease, difficulty urinating with prostate adenoma, diseases of the blood system,deficiency of the enzyme glucose-6-phosphate dehydrogenase, children under 6 years.

Carefully:

Congenital hyperbilirubinemia (Gilbert syndrome, Dubin-Johnson and Rotor syndrome), bronchial asthma and chronic obstructive pulmonary disease.

Pregnancy and lactation:Koldakt® Flu Plus suspension is not recommended for use during pregnancy and lactation.

Dosing and Administration:

Adults and children over 12 years of age: 10 ml (2 teaspoons) 3-4 times a day.

Children 6-12 years old: 5 ml (1 teaspoon) 3-4 times a day.

Duration of admission as an antipyretic agent - no more than 3 days; as an anesthetic - no more than 5 days.

Shake before use.

Side effects:

Increased blood pressure, tachycardia, drowsiness, sleep, dizziness, irritability, dry mucous membranes, mydriasis, paresis of accommodation, increased intraocular pressure, appetite loss, nausea, epigastric pain, anemia, rarely urinary retention, allergic reactions (rash, itching, urticaria, angioedema), rarely - anemia, thrombocytopenia, leukopenia, agranulocytosis; with prolonged admission in high doses, hepatotoxic and nephrotoxic action is possible.

Overdose:

Symptoms caused by paracetamol, appear after taking more than 10-15 g: pallor of the skin, decreased appetite, nausea, vomiting, hepatonecrosis, increased activity of "liver" transaminases, increased prothrombin time.

Treatment: gastric lavage in the first 6 hours, administration of donors of SH-groups and precursors of glutathione-methionine synthesis 8-9 hours after overdose and N-acetylcysteine after 12 hours.

In case of accidental overdose, immediately consult a doctor, regardless of whether any symptoms of overdose are noted or not.

Interaction:

The risk of hepatotoxic action of paracetamol increases with the simultaneous administration of barbiturates, diphenin, carbamazepine, rifampicin, zidovudine and other inducers of microsomal liver enzymes. Strengthens the effects of sedative drugs, ethanol, monoamine oxidase inhibitors. Antidepressants, phenothiazine derivatives, antiparkinsonian and antipsychotic drugs increase the risk of urinary retention, dry mouth, constipation. Glucocorticosteroids increase the risk of developing glaucoma. Paracetamol reduces the effectiveness of uricosuric drugs. Chlorphenamine simultaneously with furazolidone can lead to hypertensive crisis, p excitation, hyperpyrexia. Tricyclic antidepressants strengthen the adrenomimetic effect of phenylephrine, the simultaneous administration of halothane increases the risk of ventricular arrhythmia. Reduces the hypotensive effect of guanethidine, which, in turn, enhances the alpha-adrenostimulating activity of phenylephrine.

Special instructions:

Without the doctor's instructions, the drug should not be used by patients undergoing treatment with other medications, in particular monoamine oxidase inhibitors. If, despite taking the drug, the disease is accompanied by an ongoing fever or there are repeated increases in temperature, you need to see a doctor. Do not take with alcohol and combine with other drugs containing paracetamol. When using Flood Plus, it is undesirable to use sleeping pills, tranquilizers and other psychotropic drugs.

Distorts the indicators of laboratory studies in the quantitative determination of glucose and uric acid in plasma.

In the case of prolonged treatment, the parameters of peripheral blood and the functional state of the liver are monitored.

Effect on the ability to drive transp. cf. and fur:

During the treatment period it is necessary to refrain from driving motor vehicles and practicing potentially dangerous activities that require an increased concentration of attention and speed of psychomotor reactions.

Form release / dosage:

Suspension for oral administration.

Packaging:

60 ml of suspension in a vial of dark glass with a screwed metal lid; 1 a bottle with a measuring spoon and instructions for use in a cardboard bundle.

Storage conditions:

At a temperature of no higher than 25 ° C. Do not freeze. Keep out of the reach of children.

Shelf life:

2 years.

Do not use after expiry date.

Terms of leave from pharmacies:Without recipe

Registration number:П N013266 / 02

Date of registration:29.08.2008 / 15.05.2017

Expiration Date:Unlimited

The owner of the registration certificate:Ranbaxy Laboratories LimitedRanbaxy Laboratories Limited India

Manufacturer: & nbsp

PROMED EXPORTS, Pvt. Ltd. India

Representation: & nbspRABBAYS LABORATORY LIMITEDRABBAYS LABORATORY LIMITED

Information update date: & nbsp31.01.2018

Illustrated instructions

Instructions

Koldakt® Flu Plus (Coldact® Flu Plus)